SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Positive 24-month HOPE-3 extension data suggesting slower upper-limb deterioration in Duchenne muscular dystrophy patients treated with deramiocel is driving attention ahead of the FDA review. Traders are bullish and discuss a possible short squeeze, while others argue the open-label results may not resolve the FDAs earlier statistical concerns, leaving approval uncertain.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CEO Paul Peter Taks disclosed share sale has prompted concern about management confidence and the timing of Candels planned BLA filing for CAN-2409 in localized prostate cancer. Some traders view the sale as a negative signal and worry about delays, while others say it was preplanned and remain focused on the Phase 3 results and regulatory submission plans.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

A DEA administrative judge paused the broader cannabis rescheduling case while considering whether to add a government watchdog report to the record, delaying a Schedule III recommendation that traders had viewed as a catalyst for MSOS and other U.S. cannabis stocks. The selloff prompted debate over whether the pause signals a more serious setback or a procedural delay, with some traders calling it an overreaction and others worried the timeline could stretch further.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Citis Sell downgrade, citing valuation after Modernas sharp rally, has intensified debate over whether expectations have run ahead of the business. Bears point to the stocks steep gains and commercialization uncertainty, while bulls emphasize positive Phase 3 melanoma-vaccine results, the upcoming ESMO data presentation, and the broader potential of Modernas mRNA platform.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWM is drawing attention for persistent small-cap weakness as rising Treasury yields and renewed Fed rate-hike concerns pressure rate-sensitive companies with heavier debt and refinancing needs. Traders are split between calling for further declines and looking for an oversold bounce if yields ease or inflation and geopolitical pressures recede.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns fiscal Q4 earnings and outlook are the dominant focus, with traders watching whether AI-driven HBM and DRAM demand can sustain the memory upcycle. The community is broadly optimistic about strong results but divided over whether high expectations are already priced in and whether a cyclical downturn could trigger a sell-the-news reaction.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET is drawing attention after its reported ECOC 2026 award for the Blazar photonics platform, fueling bullish momentum and short-squeeze speculation. The reaction is tempered by calls for concrete evidence of customer orders, shipments, and production progress, which many traders say matter more than awards or broad updates.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoins rebound from a recent support zone and effort to clear near-term resistance dominate the discussion. Bulls point to dip buying and possible short covering as signs of further strength, while bears warn that a failed breakout or elevated yields could bring another pullback.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Staggered IPO lockup expirations and reported insider selling dominate discussion, with traders concerned that newly eligible shares could add supply and pressure CBRS. Bulls counter that demand for Cerebras AI-inference systems and customer partnerships support the longer-term story, leaving the stock volatile between supply concerns and dip-buying.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Cooler-than-expected August inflation data and an upward GDP revision drove discussion of the S&P 500, with bulls seeing relief on rate-hike concerns while skeptics pointed to elevated Treasury yields and oil prices and questioned the inflation figures. Traders also cited quarter-end rebalancing as a source of choppy price action.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


BullSheetTrader

James Young